255 related articles for article (PubMed ID: 9326949)
1. Deregulation of MUM1/IRF4 by chromosomal translocation in multiple myeloma.
Iida S; Rao PH; Butler M; Corradini P; Boccadoro M; Klein B; Chaganti RS; Dalla-Favera R
Nat Genet; 1997 Oct; 17(2):226-30. PubMed ID: 9326949
[TBL] [Abstract][Full Text] [Related]
2. The recurrent translocation t(14;20)(q32;q12) in multiple myeloma results in aberrant expression of MAFB: a molecular and genetic analysis of the chromosomal breakpoint.
Boersma-Vreugdenhil GR; Kuipers J; Van Stralen E; Peeters T; Michaux L; Hagemeijer A; Pearson PL; Clevers HC; Bast BJ
Br J Haematol; 2004 Aug; 126(3):355-63. PubMed ID: 15257707
[TBL] [Abstract][Full Text] [Related]
3. Genomic characterization of the chromosomal breakpoints of t(4;14) of multiple myeloma suggests more than one possible aetiological mechanism.
Fenton JA; Pratt G; Rawstron AC; Sibley K; Rothwell D; Yates Z; Dring A; Richards SJ; Ashcroft AJ; Davies FE; Owen RG; Child JA; Morgan GJ
Oncogene; 2003 Feb; 22(7):1103-13. PubMed ID: 12592397
[TBL] [Abstract][Full Text] [Related]
4. A potential role for centrosomal deregulation within IgH translocation-positive myeloma.
Maxwell CA; Pilarski LM
Med Hypotheses; 2005; 65(5):915-21. PubMed ID: 16023302
[TBL] [Abstract][Full Text] [Related]
5. Quantitation of multiple myeloma oncogene 1/interferon-regulatory factor 4 gene expression in malignant B-cell proliferations and normal leukocytes.
Yamada M; Asanuma K; Kobayashi D; Moriai R; Yajima T; Yagihashi A; Yamamori S; Watanabe N
Anticancer Res; 2001; 21(1B):633-8. PubMed ID: 11299818
[TBL] [Abstract][Full Text] [Related]
6. MUM1/IRF4 expression as a frequent event in mature lymphoid malignancies.
Tsuboi K; Iida S; Inagaki H; Kato M; Hayami Y; Hanamura I; Miura K; Harada S; Kikuchi M; Komatsu H; Banno S; Wakita A; Nakamura S; Eimoto T; Ueda R
Leukemia; 2000 Mar; 14(3):449-56. PubMed ID: 10720141
[TBL] [Abstract][Full Text] [Related]
7. Detection of MUM1/IRF4-IgH fusion in multiple myeloma.
Yoshida S; Nakazawa N; Iida S; Hayami Y; Sato S; Wakita A; Shimizu S; Taniwaki M; Ueda R
Leukemia; 1999 Nov; 13(11):1812-6. PubMed ID: 10557056
[TBL] [Abstract][Full Text] [Related]
8. Id4 is deregulated by a t(6;14)(p22;q32) chromosomal translocation in a B-cell lineage acute lymphoblastic leukemia.
Bellido M; Aventín A; Lasa A; Estivill C; Carnicer MJ; Pons C; Matías-Guiu X; Bordes R; Baiget M; Sierra J; Nomdedéu JF
Haematologica; 2003 Sep; 88(9):994-1001. PubMed ID: 12969807
[TBL] [Abstract][Full Text] [Related]
9. Chromosome translocations in multiple myeloma.
Bergsagel PL; Kuehl WM
Oncogene; 2001 Sep; 20(40):5611-22. PubMed ID: 11607813
[TBL] [Abstract][Full Text] [Related]
10. Frequent dysregulation of the c-maf proto-oncogene at 16q23 by translocation to an Ig locus in multiple myeloma.
Chesi M; Bergsagel PL; Shonukan OO; Martelli ML; Brents LA; Chen T; Schröck E; Ried T; Kuehl WM
Blood; 1998 Jun; 91(12):4457-63. PubMed ID: 9616139
[TBL] [Abstract][Full Text] [Related]
11. Identification of primary MAFB target genes in multiple myeloma.
van Stralen E; van de Wetering M; Agnelli L; Neri A; Clevers HC; Bast BJ
Exp Hematol; 2009 Jan; 37(1):78-86. PubMed ID: 19013005
[TBL] [Abstract][Full Text] [Related]
12. Promiscuous translocations into immunoglobulin heavy chain switch regions in multiple myeloma.
Bergsagel PL; Chesi M; Nardini E; Brents LA; Kirby SL; Kuehl WM
Proc Natl Acad Sci U S A; 1996 Nov; 93(24):13931-6. PubMed ID: 8943038
[TBL] [Abstract][Full Text] [Related]
13. Templated nucleotide addition and immunoglobulin JH-gene utilization in t(11;14) junctions: implications for the mechanism of translocation and the origin of mantle cell lymphoma.
Welzel N; Le T; Marculescu R; Mitterbauer G; Chott A; Pott C; Kneba M; Du MQ; Kusec R; Drach J; Raderer M; Mannhalter C; Lechner K; Nadel B; Jaeger U
Cancer Res; 2001 Feb; 61(4):1629-36. PubMed ID: 11245476
[TBL] [Abstract][Full Text] [Related]
14. Multicolor interphase cytogenetics for the study of plasma cell dyscrasias.
Sáez B; Martín-Subero JI; Odero MD; Prosper F; Cigudosa JC; Schoch R; Calasanz MJ; Siebert R
Oncol Rep; 2007 Nov; 18(5):1099-106. PubMed ID: 17914559
[TBL] [Abstract][Full Text] [Related]
15. Chromosomal translocations and gene rearrangements in non-Hodgkin lymphomas.
Yunis JJ
Cancer Detect Prev; 1988; 12(1-6):291-6. PubMed ID: 3141052
[TBL] [Abstract][Full Text] [Related]
16. Alternative translocation breakpoint cluster region 5' to BCL-6 in B-cell non-Hodgkin's lymphoma.
Butler MP; Iida S; Capello D; Rossi D; Rao PH; Nallasivam P; Louie DC; Chaganti S; Au T; Gascoyne RD; Gaidano G; Chaganti RS; Dalla-Favera R
Cancer Res; 2002 Jul; 62(14):4089-94. PubMed ID: 12124346
[TBL] [Abstract][Full Text] [Related]
17. Expression of fibroblast growth factor and FGF-receptor family genes in human myeloma cells, including lines possessing t(4;14)(q16.3;q32. 3) and FGFR3 translocation.
Otsuki T; Yamada O; Yata K; Sakaguchi H; Kurebayashi J; Nakazawa N; Taniwaki M; Yawata Y; Ueki A
Int J Oncol; 1999 Dec; 15(6):1205-12. PubMed ID: 10568829
[TBL] [Abstract][Full Text] [Related]
18. [Cytogenetic and molecular basis of multiple myeloma].
Taniwaki M; Matsumoto Y
Nihon Rinsho; 2007 Dec; 65(12):2179-86. PubMed ID: 18069258
[TBL] [Abstract][Full Text] [Related]
19. Identification of overexpressed genes in frequently gained/amplified chromosome regions in multiple myeloma.
Largo C; Alvarez S; Saez B; Blesa D; Martin-Subero JI; González-García I; Brieva JA; Dopazo J; Siebert R; Calasanz MJ; Cigudosa JC
Haematologica; 2006 Feb; 91(2):184-91. PubMed ID: 16461302
[TBL] [Abstract][Full Text] [Related]
20. [The origin and formation of chromosomal translocations in multiple myeloma].
Nemec P; Kuglík P; Hájek R
Klin Onkol; 2008; 21(2):53-8. PubMed ID: 19102212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
